Effect of ebselen on IL-1-induced alterations in cartilage metabolism

Inflammation Research

Volumn 47, Issue 3, 1998, Pages 115-121

  Pratta, M A ^a   Ackerman, N R ^b   Arner, E C ^a  

^a DUPONT COMPANY   (United States)

^b Cygnus Therapeutic Systems   (United States)

Author keywords

Cartilage; Isothiazalone; Matrix metalloproteinase; Proteoglycan

Indexed keywords

EBSELEN; GLUTATHIONE PEROXIDASE; GLYCOSAMINOGLYCAN POLYSULFATE; INTERLEUKIN 1; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; PROTEOGLYCAN;

ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CARTILAGE DEGENERATION; NONHUMAN; ORGAN CULTURE; PROSTAGLANDIN RELEASE; PROTEOGLYCAN SYNTHESIS; RADIOIMMUNOASSAY;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIOXIDANTS; ARTHRITIS; AZOLES; CARTILAGE; CATTLE; CYCLOOXYGENASE INHIBITORS; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUTATHIONE DISULFIDE; GLUTATHIONE PEROXIDASE; GLYCOSAMINOGLYCANS; INFLAMMATION; INTERLEUKIN-1; NADP; ORGAN CULTURE TECHNIQUES; ORGANOSELENIUM COMPOUNDS; PROTEOGLYCANS;

EID: 0031919829     PISSN: 10233830     EISSN: None     Source Type: Journal    
DOI: 10.1007/s000110050296     Document Type: Article

References (39)

1. Mankin HJ, Lippiello L. Biochemical and metabolic abnormalities in articular cartilage from osteoarthritic hips. J Bone Joint Surg (Am) 1970;52:424-34.
2. Armstrong CG, Mow VK. Biomechanics of normal and osteoarthritic articular cartilage. In: Straub IR, Wilson PD, editors. Clinical Trends in Orthopaedics. New York: Grune & Straton, 1982:189-97.
3. Brazel D, Nakanishi S, Oster W. Interleukin-1, characterization of the molecule, functional activity, and clinical implications. Biotechnol Ther 1991;2:241-67.
4. Nouri AM, Panayi GS, Goodman SM. Cytokines and the chronic inflammation of rheumatic disease. I. The presence of interleukin-1 in synovial fluids. Clin Exp Immunol 1984;55:295-302.
5. Wood DD, Ihrie EJ, Dinarello CA, Cohen PL. Isolation of an interleukin-1-like factor from human joint effusions. Arthritis Rheum 1983;26:975-83.
6. Mizel SB, Dayer JM, Krane SM, Mergenhagen SS. Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci USA 1981;78:2474-77.
7. Postlethwaite AE, Lachman LB, Mainardi CL, Kang AH. Interleukin-1 stimulation of collagenase production by cultured fibroblasts. J Exp Med 1983;157:801-6.
8. Gowen M, Wood DD, Ihrie EJ, Meats JE, Russell RGG. Stimulation by human interleukin-1 of cartilage breakdown and production of collagenase and proteoglycanase by human chondrocytes but not human osteoblasts in vitro. Biochim Biophys Acta 1984;747:186-93.
9. Saklatvala J. Characterization of catabolin, the major product of pig synovial tissue that induces resorption of cartilage proteoglycan in vitro. Biochem J 1981;199:705-14.
10. Tyler JA. Chondrocyte-mediated depletion of articular cartilage proteoglycans in vitro. Biochem J 1985;225:493-507.
11. Tyler JA. Articular cartilage cultured with catabolin (pig interleukin-1) synthesizes a decreased number of normal proteoglycan molecules. Biochem J 1985;227:869-78.
12. Dingle JT. The effect of synovial catabolin on cartilage synthetic activity. Connect Tissue Res 1984;12:277-86.
13. Saklatvala J. Characterization of catabolin, the major product of pig synovial tissue that induces resorption of cartilage proteoglycan in vitro. Biochem J 1981;199:705-14.
14. Saklatvala J, Sarsfield SJ, Pilsworth LMC. Characterization of proteins from human synovium and mononuclear leukocytes that induce resorption of cartilage proteoglycan in vitro. Biochem J 1983;209:337-44.
15. Saklatvala J, Pilsworth LM, Sarsfield SJ, Gavrilovic J, Heath JK. Pig catabolin is a form of interleukin 1. Cartilage and bone resorb, fibroblasts make prostaglandin and collagenase, and thymocyte proliferation is augmented in response to one protein. Biochem J 1984;224:461-6.
16. Hubbard JR, Steinberg JJ, Bednar MS, Sledge CB. Effect of purified human interleukin-1 on cartilage degradation. J Orthop Res 1988;6:180-7.
17. Steinberg J, Sledge CB, Noble J, Stirrat CR. A tissue-culture model of cartilage breakdown in rheumatoid arthritis. Biochem J 1979;180:403-12.
18. Smith RJ, Rohloff NA, Sam LM, Justen JM, Deibel MR, Cornette JC. Recombinant human interleukin-1α and recombinant human interleukin-1β stimulate cartilage matrix degradation and inhibit glycosaminoglycan synthesis. Inflammation 1989;13:367-82.
19. Pettipher ER, Higgs GA, Henderson B. Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986;83:8749-53.
20. Dingle JT, Page Thomas DP, King B, Bard DR. In vivo studies of articular tissue damage mediated by catabolin/interleukin 1. Ann Rheum Dis 1987;46:527-33.
21. 2 release from cartilage in organ culture. Arthritis Rheum 1989;32:288-97.
22. Pettipher ER, Henderson B, Edwards JCW, Higgs GA. Effect of indomethacin on swelling, lymphocyte influx, and cartilage proteoglycan depletion in experimental arthritis. Ann Rheum Dis 1989;48:623-7.
23. Muller A, Cadenas E, Graf P, Sies H. A novel biologically active seleno-organic compound. I. Glutathione peroxidase-like activity in vitro and antioxidant capacity of PZ51 (ebselen). Biochem Pharmacol 1984;33:3235-9.
24. Wendel A, Fausel M, Safayhi H, Tiegs G, Otter R. A novel biologically active seleno-organic compound. II. Activity of PZ51 in relation to glutathione peroxidase. Biochem Pharmacol 1984;33:3241-5.
25. Maiorino M, Roveri A, Coassin M, Ursini F. Kinetic mechanism and substrate specificity of glutathione peroxidase activity of ebselen (PZ51). Biochem Pharmacol 1988;37:2267-71.
26. Parnham MJ, Kindt S. A novel biologically active seleno-organic compound. III. Effects of PZ51 (ebselen) on glutathione peroxidase and secretory activities of mouse macrophages. Biochem Pharmacol 1984;33:3247-50.
27. Hemler ME, Lands WEM. Evidence for a peroxide-initiated free radical mechanism of prostaglandin biosynthesis. J Biol Chem 1980;255:6253-61.
28. Lunec J, Halloran SP, White AG, Dormandy TL. Free radical oxidation (peroxidation) products in serum and synovial fluid in rheumatoid arthritis. J Rheumatol 1981;8:233.
29. Huang JJ, Newton RC, Pezzella K, Covington M, Tamblyn T, Rutledge SJ, et al. High-level expression in Escherichia coli of a soluble and fully active recombinant interleukin-1 β. Mol Biol Med 1987;4:169-81.
30. Farndale RW, Sayers CA, Barrett AJ. A direct spectrophotometric microassay for sulfated glycosaminoglycans in cartilage cultures. Connect Tissue Res 1982;9:247-8.
31. CRC Handbook of Methods for Oxygen Radical Research. In: Greenwald RA, editor. Boca Raton: CRC Press, 1985:294-6.
32. Gans KR, Galbraith W, Roman RJ, Haber SB, Kerr JS, Schmidt WK, et al. J Pharmacol Exp Ther 1990;254:180-7.
33. Smith RJ, Chin JE, Sam LM, Justen JM. Biologic effects of interleukin-1 receptor antagonist protein on interleukin-1-stimulated cartilage erosion and chondrocyte responsiveness. Arthritis Rheum 1991;34:78-83.
34. Smith CA, Davis T, Anderson D, Solam L, Beckmann MP, Jerzy R, et al. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins. Science 1990;248:1019-23.
35. Saklatvala J. Tumor necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage. Nature 1986;322: 547-9.
36. Pratta MA, DiMeo TM, Ruhl DM, Arner EC. Effect of interleukin-1 β and tumor necrosis factor α on cartilage proteoglycan metabolism in vitro. Agents Actions 1989;27:250-3.
37. Rainsford KD. Effects of anti-inflammatory drugs on interleukin-1-induced cartilage proteoglycan resorption in-vitro: Inhibition by aurothiophosphines but no influence from perturbed eicosanoid metabolism. J Pharm Pharmacol 1988;41:112-7.
38. Arner EC, Pratta MA, Freimark B. Lischwe M, Trzaskos JM, Magolda RL, et al. Isothiazalones interfere with normal matrix metalloproteinase activation and inhibit cartilage proteoglycan degradation. Biochem J 1986;318:417-24.
39. Tortorella MD, Hughes CE, Wang H, Caterson B, Decicco CP, Arner EC. MMP inhibitors block IL-1-induced 'aggrecanase' cleavage of cartilage proteoglycan. Transactions of the Orthopaedic Research Society 1996;21:148.